Vitra Pharmaceuticals Private Limited
About Vitra Pharmaceuticals Private Limited
Data last updated:
Vitra Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2020PTC362061.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajesh Kumar and Hukam Chand Malik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 101 Plot No. 4 1st Floor Garg Trade Centre Sec – 11 Rohini, New Delhi, Delhi, India – 110086.
Company details
Contact details
Vitra Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No. 101 Plot No. 4 1st Floor Garg Trade Centre Sec – 11 Rohini, New Delhi, Delhi, India – 110086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vitra Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vitra Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Vitra Pharmaceuticals Private Limited
FY 2025 filings availableVitra Pharmaceuticals Private Limited reported revenue of ₹9,939 (down 79% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 79% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹9,939 | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vitra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vitra Pharmaceuticals Private Limited
Vitra Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Also directs: Medicity Packaging Private Limited, Adkin Bioceuticals Private Limited, Sonesta Pharmaceuticals Private Limited and 1 more | Director | 14 May 2022 | 4 Years 5 Months | Current |
| Hukam Chand Malik | Director | 14 May 2022 | 4 Years 5 Months | Current |
Auditor
Vitra Pharmaceuticals Private Limited is audited by ANEJA KAMBOJ & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANEJA KAMBOJ & CO. | FY 2023 | 013748N |
Shareholding
The shareholding of Vitra Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vitra Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vitra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vitra Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vitra Pharmaceuticals Private Limited has 8 board changes on record since 2020: 5 appointments and 3 cessations. The latest: Deepak Bambha ceased to be Director on 16 May 2022.
Frequently asked questions
Vitra Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 February 2020 (6+ years old) and is registered under CIN U24230DL2020PTC362061.
Vitra Pharmaceuticals has 2 current directors:
- Rajesh Kumar - Director
- Hukam Chand Malik - Director
The latest financial statements of Vitra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Vitra Pharmaceuticals is U24230DL2020PTC362061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitra Pharmaceuticals was incorporated on 18 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Deepak Bambha ceased to be Director on 16 May 2022. Raja Ram ceased to be Director on 16 May 2022. Sanjay Pahal ceased to be Director on 16 May 2022. Vitra Pharmaceuticals has 8 board changes on record in total.
The registered office of Vitra Pharmaceuticals is at Unit No. 101 Plot No. 4 1st Floor Garg Trade Centre Sec – 11 Rohini, New Delhi, Delhi, India – 110086.
Vitra Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Vitra Pharmaceuticals can be reached at its registered office: Unit No. 101 Plot No. 4 1st Floor Garg Trade Centre Sec – 11 Rohini, New Delhi, Delhi, India – 110086.
Vitra Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.